+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas

Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas

Journal of Pathology 182(1): 62-67

The aim of the present study was to clarify the conflicting recorded data on the proliferative features of gastric carcinoma. The Ki67 labelling index (Ki67 LI) was evaluated using MIB-1 in 43 carcinomas (24 diffuse and 19 intestinal). In 18 cases, differential counts were performed in superficial and deep layers. In ten diffuse carcinomas with a prominent desmoplastic response, Ki67 LI was evaluated in sections double-stained with MIB-1 and CAM5.2. Flow cytometry was performed in 26 cases. Ki67 LI of diffuse carcinomas (36.3 +/- 19.0) was not significantly different from that of intestinal carcinomas (28.2 +/- 18.5). Ki67 LI was significantly higher (P = 0.006) in superficial than in deep areas (41.9 +/- 22.7 and 29.7 +/- 19.7, respectively) regardless of histological tumour type. No significant relationship was observed between Ki67 LI and wall invasion, lymph node metastasis, vascular invasion or ploidy. The following conclusions were drawn: double immunostaining techniques are apparently the best way to overcome the underestimation of cell proliferation in diffuse gastric carcinomas with a prominent desmoplastic response; the diffuse and intestinal types of gastric carcinoma have proliferation rates within the same range, even when the comparison is restricted to diploid tumours; and, finally, the major pool of proliferating cells resides in the superficial areas of gastric carcinomas, regardless of the histotype, which should be taken into consideration when overall counts are performed, using either immunohistochemical markers in tissue sections or suspensions of nuclei in flow cytometry.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 008934351

Download citation: RISBibTeXText

PMID: 9227343

DOI: 10.1002/(sici)1096-9896(199705)182:1<62::aid-path849>3.0.co;2-2

Related references

Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1. Pathology Research and Practice 214(10): 1707-1712, 2018

Evaluation of hepatic proliferative activity in chronic liver diseases and hepatocellular carcinomas by proliferating cell nuclear antigen (PCNA) immunohistochemical staining of methanol-fixed tissues. Journal of Gastroenterology 29(4): 450-454, 1994

Immunohistochemical expression of TGF-beta1, p21WAF1, p53, Ki67, and angiogenesis in gastric carcinomas: a clinicopathologic study. International Journal of Gastrointestinal Cancer 32(2-3): 83-89, 2002

Proliferative Index (Ki67) for Prediction in Breast Duct Carcinomas. Asian Pacific Journal of Cancer Prevention 19(4): 955-959, 2018

Metastasizing intramucosal gastric carcinomas: Well differentiated type and proliferative activity using proliferative cell nuclear antigen and Ki-67. Cancer 75(4): 926-935, 1995

Proliferative activity in adenoid cystic carcinomas an immunohistochemical analysis of proliferating cell nuclear antigen index. Pathology Research & Practice 187(6): 658, 1991

Immunohistochemistry of a proliferation marker Ki67/MIB1 in adrenocortical carcinomas: Ki67/MIB1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocrine Journal 55(1): 49-55, 2008

Enhanced expression of decay-accelerating factor and CD59/homologous restriction factor 20 in intestinal metaplasia, gastric adenomas and intestinal-type gastric carcinomas but not in diffuse-type carcinomas. Histopathology (Oxford) 40(4): 339-347, 2002

Proliferative Activity of Myoepithelial Cells in Normal Salivary Glands and Adenoid Cystic Carcinomas Based on Double Immunohistochemical Labeling. Asian Pacific Journal of Cancer Prevention 19(7): 1965-1970, 2018

Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining. Breast Cancer Research and Treatment 158(1): 11-19, 2016

Comparative study of PCNA and Ki-67 immunohistochemical staining in psoriasis, basal cell carcinomas and squamous cell carcinomas. Annals of Dermatology 6(2): 146-151, 1994

Expression of cell cycle proteins p53, p21, p27, p14 and p16 and proliferation index ki67 in gastric carcinomas. 2008

P53 overexpression and proliferative activity in oral squamous cell carcinomas A quantitative immunohistochemical study. Pathology Research & Practice 189(6-7): 843, 1993

Correlation between iododeoxyuridine and MIB-1 labelling index in gastric carcinomas and adjacent normal gastric tissue. Gastroenterology 114(4 Part 2): A673, 1998

Discontinuity of the basement membrane in fibrosing basocellular carcinomas and basosquamous carcinomas of the skin: an immunohistochemical study with human laminin and type IV collagen antibodies. Journal of Investigative Dermatology 82(3): 248-251, 1984